Alto Neuroscience Inc.
ANRO
Get informed when a big investor buys or sells
+ FollowMarket Cap$704.34M
Close$
$5.96
68.4% downside
Current Fair Value
68.4% downsideOvervalued by 68.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $704.34 Million |
|---|---|
| Enterprise Value | $446.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.19 |
| Beta | 1.65 |
| Outstanding Shares | 32,893,000 |
Return
| Return on Equity | -30.53% |
|---|---|
| Return on Assets | -26.90% |
| Return on Invested Capital | -29.04% |
Valuation & Multiples
| P/E Ratio | -8.88 |
|---|---|
| PEG | -12.18 |
| Price to Sales | - |
| Price to Book Ratio | 2.69 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.84 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.53
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.75
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0339▲ 3.39% |
|---|---|
| Total Calls | 462,500▲ 4.28% |
| Total Puts | 15,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.99%▲ 1.86% |
|---|---|
| Total Invested | $602.48M▲ 34.91% |
| Investors Holding | 114▲ 13.00% |
ESG Score
No data